Latest Stock Market stories from Money.
Fractyl Health, Inc. has released findings from their REMAIN-1 study, showcasing the effectiveness of their treatment in maintaining weight after GLP-1 therapy ends.
BlackRock's impressive Q2 results have prompted analysts to upgrade their ratings, presenting a compelling buy opportunity for investors.
Despite its status as a Dividend King, Emerson Electric's current valuation suggests that investors should be cautious before buying.
For the first time, SpaceX's stock has fallen below its IPO price, marking a significant decline in market value. Analysts are concerned about potential further drops.
A detailed analysis of the Artisan Mid Cap Fund's performance and market conditions for the second quarter of 2026.
This article delves into the financial challenges Airbnb faces in creating a market and the regulatory hurdles that threaten its business model.
Bank Of New York Mellon has achieved back-to-back record quarters, prompting an increase in its target price. This analysis explores the factors behind its strong performance.
Explore why Nebius is regarded as a high-conviction stock in the AI sector, with insights into its market position and growth prospects.
Explore the trends in Master Limited Partnerships (MLPs) distributions and their implications for investors in the stock market.
On Tuesday, the stock market showcased significant movements, leading to fresh investment opportunities. Here are four ideas to consider.
Gladstone Capital has been upgraded, indicating it may be a valuable addition to investment portfolios. Here's what you need to know.
Post Holdings is on a path of re-rating, bolstered by a strategic buyback plan that aims for double-digit returns, attracting investor interest.
Karat Packaging is currently assessed as fairly valued, but improvements in margins are necessary for a more positive outlook.
This article explores BorgWarner's shift from a deep value stock to a balanced buy, highlighting its financial improvements and investment potential.
A prominent developer in the Delhi-NCR region has reported a 25% quarter-over-quarter increase in pre-sales value, leading to a 9% rise in its stock price.
The premium on SK Hynix’s American Depositary Receipts (ADRs) could diminish if the Korean depository permits conversion, raising questions for investors.
Sterling and Wilson Renewable Energy's Australian subsidiary has filed for arbitration against Shell New Energies Australia, claiming damages related to the Gangarri Solar Farm project.
Hemab Therapeutics stands out in the coagulation sector with a robust financial foundation and several key clinical developments on the way.
This commentary provides insights into the Thrivent Global Stock Fund's performance during the second quarter of 2026, highlighting key market trends and future strategies.
The gold market in China has shown contrasting trends in the first half of 2026, with June marking a pivotal month for investors.